All News

These 4 studies were pegged as “ones to watch” during the American College of Cardiology (ACC) annual briefing on results for consumers. They will be presented in the opening session of late-breaking clinical trial results on day 1 of ACC.21.

It has been really tricky to identify and appropriately treat vaping-associated lung diseases in the time of COVID-19, said Laura Crotty Alexander, MD, ATSF.

In order to properly help patients manage their disease, it is critical for clinicians to recognize the differences in prevalence, severity, and persistency of atopic dermatitis among different demographics, said Jonathan Silverberg, MD, PhD, MPH.

Bruce House in Ottawa, Ontario, Canada, has been serving individuals living with HIV and AIDS for 33 years, and in this interview, Doug Cooper, former manager of client programs and services, discusses the history of the organization.

Fourteen months after the American College of Cardiology (ACC) switched its 17,000-person meeting to a virtual format on short notice, the meeting will be online May 15-17 for the second year. The 70th Scientific Session will feature 25 late-breaking clinical trials, emphasizing treatment of heart failure and the right aspirin dose for prevention of secondary cardiovascular disease.

Using biomarkers to guide treatment decisions are increasingly being leveraged across various cancers, and metastatic colorectal cancer (mCRC) is no exception. However, the positivity rates of these biomarkers can differ across different patient characteristics, according to a recent study.

Amid stay-at-home orders during the COVID-19 pandemic, patients with advanced Parkinson disease were shown to exhibit significantly higher prevalence of anxiety and feelings of worry related to interruption of treatment and risk of infection.

To mark National Women's Health Week, The American Journal of Managed Care® assesses challenges posed to women in the United States by the pandemic and looks ahead to potential long-term consequences.

The 4-day annual meeting of ISPOR—The Professional Society for Health Economics and Outcomes Research—will cover a wide range of topics. Here are 5 themes to keep an eye out for.

According to the researchers, their study is the first to assess the impact of oral targeted therapies among a large number of adolescents and young adults (AYA) patients with chronic lymphocytic leukemia (CLL).

This article is co-written by Suzanne Delbanco, PhD, MPH, executive director, Andréa Caballero, MPA, program director, and Julianne McGarry, MPP, director of projects and research, for Catalyst for Payment Reform, and Robert S. Galvin, MD, chief executive officer, Equity Healthcare, LLC.

Progressive resistance training was shown to positively alter several measures of disease progression in the study cohort: fatty acid, phospholipid, and sex steroid metabolism.

We’re going to celebrate and refocus on the science, reflect and share lessons learned from the pandemic, and really engage our audience in discussions that cover care guidelines and nontraditional pathways of care, said Pamela Bowe Morris, MD, chair of ACC.21.

Rates of COVID-19 deaths have fallen to their lowest point in 10 months in the United States; survey reveals America's public health agencies face significant trust barriers; data from California highlight vaccine administration disparities.

Attribution algorithms for patients with newly diagnosed cancer should account for cancer type and stage, among other characteristics, to ensure that attribution measurements are accurately calculated, investigators concluded.

Panelists of a session at the Pharmacy Quality Alliance (PQA) 2021 Annual Meeting discuss challenges contributing to health inequities in patient care, particularly medication use quality, as well as efforts to improve these issues.

Understanding that there is a third type of heart failure will further our understanding of the disease, noted Clyde W. Yancy, MD, MSc, chief of cardiology and vice dean for diversity and inclusion at Northwestern University's Feinberg School of Medicine.

A novel biologic for severe asthma reduced exacerbations by 56%, according to a study published Wednesday in The New England Journal of Medicine.

Vaping and other key respiratory issues, such as asthma, COPD, and new biologics, join COVID-19 on the ATS 2021 International Conference agenda.

To mark International Nurses Day, we look at factors contributing to workload burden and burnout in nurses, which include electronic health record (EHR) management, understaffing amid the COVID-19 pandemic, and a lack of emotional support.

Data show male migraineurs are nearly 6 times as likely to develop abdominal aortic aneurysms compared with healthy females.

The American Medical Association announces an antiracism plan; CMS requires nursing homes to report vaccination rates; a minority of COVID-19 carriers are responsible for the bulk of a community's virus spread.

Asthma exacerbations among Black/African American and Hispanic/Latinx adults with moderate-to-severe asthma decreased by approximately 40% during the COVID-19 pandemic, particularly among individuals who worked outside the home and those without type 2 inflammation.

Joe Zein, MD, PhD, discusses what to expect from his talk on sex differences in asthma at this year's American Thoracic Society (ATS) meeting.

Abner Mason, CEO and founder of ConsejoSano, highlights how lessons learned from his early days in the fight against HIV and AIDS in Africa can inform improvements in health equity, especially in light of the COVID-19 pandemic.

There is a persistent gap in heart failure care regarding administration of life-saving therapies outlined in clinical practice guidelines and consensus documents, noted James Jacuzzi, MD, of Harvard Medical School and an ACC trustee.

Under the lawsuit, Alvotech alleges that AbbVie is unlawfully taking advantage of patent laws and claims courts to prevent biosimilar competition rivaling its blockbuster drug, Humira, from entering the US market.

Sleep disorders were found to be associated with significantly higher rates of health care utilization and cost, accounting for $94.9 billion in costs each year in the United States.